WEDINOS DAN 24/7 Public Health Wales Welsh Government Naloxone saves lives


Type Psychoactive
Legal Status Class C
Zopiclone is a non-benzodiazepine sedative from the cyclopyrrolone family of drugs and is prescribed for the short-term management of severe Insomnia. It has a Sedative effect and is used to induce sleep for a short period of time. Some users may crush the tablets to inject but this is rare due to this method being very messy and dangerous. These medicines do not dissolve and if attempted to be injected is likely to cause damage to the veins, resulting in abscesses, Deep Vein Thrombosis (DVT), aneurysm, ulcers and varicose veins.
Addiction Potential
Dependence and Tolerance can develop with prologed use of Zopiclone.
Short Term Effects
Breathing & heart rate slow down, depressed respiratory function, high potential for abuse. Depressed mental activity and alertness, memory loss, loss of co-ordination, amnesia, paranoid behaviour and aggression. Overdose - this risk is increased if used with Alcohol, Opiates or other Sedative / Depressant substances, risk of Coma and death. Zopiclone may interact with a number of other medicines.
Long Term Effects
Dependence, risk of Coma and death. Research has shown that, even at prescribed doses, prolonged use of zopiclone may cause cancer that may affect the brain, lung, bowel, breast and bladder. Zopiclone can also have an adverse effect on the immune system increasing the risk of infections and colds, and is not recommended for people with liver or kidney disease, or women who are pregnant or breast-feeding.